0001578563-24-000391.txt : 20240823 0001578563-24-000391.hdr.sgml : 20240823 20240823163139 ACCESSION NUMBER: 0001578563-24-000391 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240823 DATE AS OF CHANGE: 20240823 EFFECTIVENESS DATE: 20240823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-522335 FILM NUMBER: 241236729 BUSINESS ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-855-2100 MAIL ADDRESS: STREET 1: 101 GLEN LENNOX DRIVE STREET 2: SUITE 300 CITY: CHAPEL HILL STATE: NC ZIP: 27517 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 D 1 primary_doc.xml X0708 D LIVE 0000034956 TENAX THERAPEUTICS, INC. 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC NORTH CAROLINA 27517 919-855-2100 DELAWARE OXYGEN BIOTHERAPEUTICS, INC. SYNTHETIC BLOOD INTERNATIONAL INC SINEQUANON CORP Corporation true Christopher T. Giordano c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director President and Chief Executive Officer Lawrence R. Hoffman c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Interim Chief Financial Officer Michael Davidson c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Director Declan Doogan c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Director Gerald T. Proehl c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Director Robyn M. Hunter c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Director Stuart Rich c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Chief Medical Officer June Almenoff c/o Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Ste 300 Chapel Hill NC NORTH CAROLINA 27517 Director Pharmaceuticals Decline to Disclose 06b false 2024-08-08 false true true true false 0 Leerink Partners LLC 39011 None None 53 State Street 40th Floor Boston MA MASSACHUSETTS 02109 All States false Guggenheim Securities, LLC 40638 None None 330 Madison Avenue New York NY NEW YORK 10017 All States false William Blair & Company, L.L.C. 1252 None None 150 North Riverside Plaza Chicago IL ILLINOIS 60606 All States false Roth Capital Partners, LLC 15407 None None 888 San Clemente Drive Newport Beach CA CALIFORNIA 92660 All States false 174999993 99681169 75318824 The Total Remaining to be Sold represents pre-funded warrants and warrants issued at closing that have not been exercised. false 24 6830870 0 0 Other than the payment of salaries and other compensation and reimbursement of expenses, no officer, director or promoter will receive any payments from the proceeds of this offering. false TENAX THERAPEUTICS, INC. /s/ Lawrence R. Hoffman Lawrence R. Hoffman Interim Chief Financial Officer 2024-08-21